BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28921839)

  • 1. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
    Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
    Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
    De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
    Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G; Brown J; Shafford E; Brock P; De Camargo B; Keeling JW; Vos A; Philips A; Pritchard J; Plaschkes J
    Cancer; 2000 Oct; 89(8):1845-53. PubMed ID: 11042582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
    Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
    Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of pulmonary metastases in hepatoblastoma--is the prognosis always poor?
    Wanaguru D; Shun A; Price N; Karpelowsky J
    J Pediatr Surg; 2013 Dec; 48(12):2474-8. PubMed ID: 24314189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
    Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine and irinotecan in children with relapsed hepatoblastoma: a single-institution experience.
    Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
    Pediatr Hematol Oncol; 2015 Feb; 32(1):18-25. PubMed ID: 24852330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?
    Fonseca A; Gupta A; Shaikh F; Ramphal R; Ng V; McGilvray I; Gerstle JT
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
    Meyers RL; Katzenstein HM; Krailo M; McGahren ED; Malogolowkin MH
    J Pediatr Surg; 2007 Dec; 42(12):2050-6. PubMed ID: 18082706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of multimodality treatment on advanced pediatric hepatoblastoma.
    Zhang Y; Zhang WL; Huang DS; Hong L; Wang YZ; Zhu X; Hu HM; Zhang PW; Yi Y; Han T
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1018-26. PubMed ID: 24763882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.